{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T15:21:28Z","timestamp":1648567288073},"reference-count":23,"publisher":"Japanese Society of Internal Medicine","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2021,11,1]]},"DOI":"10.2169\/internalmedicine.7269-21","type":"journal-article","created":{"date-parts":[[2021,5,21]],"date-time":"2021-05-21T22:08:33Z","timestamp":1621634913000},"page":"3453-3458","source":"Crossref","is-referenced-by-count":1,"title":["Acute Brachial Arterial Embolic Occlusion Following Anticoagulant Discontinuation in a Renal Biopsy of a Nephrotic Syndrome Patient"],"prefix":"10.2169","volume":"60","author":[{"given":"Tomoki","family":"Taniguchi","sequence":"first","affiliation":[{"name":"Department of Nephrology, Kyoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mayumi","family":"Tomita","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kyoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Ikeda","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kyoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Kamimatsuse","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kyoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kojiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kyoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ai","family":"Shimizu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kyoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Yanai","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kyoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Kamata","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kyoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriyuki","family":"Iehara","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Kyoto City Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Bakdash K, Schramm KM, Annam A, Brown M, Kondo K, Lindquist JD. Complications of percutaneous renal biopsy. Semin Intervent Radiol 36: 97-103, 2019.","DOI":"10.1055\/s-0039-1688422"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Xu DM, Chen M, Zhou FD, Zhao MH. Risk factors for severe bleeding complications in percutaneous renal biopsy. Am J Med Sci 353: 230-235, 2017.","DOI":"10.1016\/j.amjms.2016.12.019"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Dara T, Lohr J. Disseminated intravascular coagulation following percutaneous renal biopsy. Am J Nephrol 11: 343-344, 1991.","DOI":"10.1159\/000168335"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nagata H, Sato M, Ogura M, et al. Coagulopathy as a complication of kidney biopsies in paediatric systemic lupus erythematosus patients with antiphospholipid syndrome. Nephrology (Carlton) 23: 592-596, 2018.","DOI":"10.1111\/nep.13175"},{"key":"5","unstructured":"5. Hirakata H, Morozumi K, Ishimura E, et al. [Guidebook of the renal biopsy]. 1st ed. Tokyo Igakusha, Tokyo, 2004: 44 (in Japanese)."},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Shima N, Hayami N, Mizuno H, et al. Arteriovenous fistula-related renal bleeding 5 days after percutaneous renal biopsy. CEN Case Rep 8: 280-284, 2019.","DOI":"10.1007\/s13730-019-00408-1"},{"key":"7","unstructured":"7. Ubara Y, Tsuruya K, Katsuno T, et al. [Guidebook of the renal biopsy]. 2nd ed. Tokyo Igakusha, Tokyo, 2020: 54-55 (in Japanese)."},{"key":"8","unstructured":"8. Kato M, Uedo N, Hokimoto S, et al. [Guidelines for gastroenterological endoscopy in patients undergoing antithrombotic treatment]. Gastroenterol Endosc 59: 1547-1558, 2017 (in Japanese)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Douketis JD, Spyropoulos AC, Spencer FA, et al. Perioperative management of antithrombotic therapy. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141: E326S-E350S, 2012.","DOI":"10.1378\/chest.11-2298"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Lees JS, McQuarrie EP, Mordi N, Geddes CC, Fox JG, Mackinnon B. Risk factors for bleeding complications after nephrologist-performed native renal biopsy. Clin Kidney J 10: 573-577, 2017.","DOI":"10.1093\/ckj\/sfx012"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Shidham GB, Siddiqi N, Beres JA, et al. Clinical risk factors associated with bleeding after native kidney biopsy. Nephrology (Carlton) 10: 305-310, 2005.","DOI":"10.1111\/j.1440-1797.2005.00394.x"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Korbet SM, Gashti CN, Evans JK, Whittier WL. Risk of percutaneous renal biopsy of native kidneys in the evaluation of acute kidney injury. Clin Kidney J 11: 610-615, 2018.","DOI":"10.1093\/ckj\/sfy048"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Fisi V, Maz\u00e1k I, Degrell P, et al. Histological diagnosis determines complications of percutaneous renal biopsy: a single-center experience in 353 patients. Kidney Blood Press Res 35: 26-34, 2012.","DOI":"10.1159\/000329939"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Eiro M, Katoh T, Watanabe T. Risk factors for bleeding complications in percutaneous renal biopsy. Clin Exp Nephrol 9: 40-45, 2005.","DOI":"10.1007\/s10157-004-0326-7"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Vilet JMM, Mart\u00ednez MAM, Sanchez BMC, Ibarg\u00fcengoitia MC, Rotter RC, Buenrostro LEM. Simple risk score for prediction of haemorrhagic complications after a percutaneous renal biopsy. Nephrology (Carlton) 23: 523-529, 2018.","DOI":"10.1111\/nep.13055"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Chikamatsu Y, Matsuda K, Takeuchi Y, et al. Quantification of bleeding volume using computed tomography and clinical complications after percutaneous renal biopsy. Clin Kidney J 10: 9-15, 2017.","DOI":"10.1093\/ckj\/sfw131"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. T\u00f8ndel C, Vikse BE, Bostad L, Svarstad E. Safety and complications of percutaneous kidney biopsies in 715 children and 8573 adults in Norway 1988-2010. Clin J Am Soc Nephrol 7: 1591-1597, 2012.","DOI":"10.2215\/CJN.02150212"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Vene N, Mavri A, Guben\u0161ek M, et al. Risk of thromboembolic events in patients with non-valvular atrial fibrillation after dabigatran or rivaroxaban discontinuation - data from the Ljubljana Registry. PLoS One 11: e0156943, 2016.","DOI":"10.1371\/journal.pone.0156943"},{"key":"19","unstructured":"19. Patel MR, Hellkamp AS, Lokhnygina Y, et al. Outcomes of discontinuing rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: analysis from the ROCKET AF trial (rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). J Am Coll Cardiol 61: 651-658, 2013."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Kerlin BA, Ayoob R, Smoyer WE. Epidemiology and pathophysiology of nephrotic syndrome - associated thromboembolic disease. Clin J Am Soc Nephrol 7: 513-520, 2012.","DOI":"10.2215\/CJN.10131011"},{"key":"21","doi-asserted-by":"publisher","unstructured":"21. Mahmoodi BK, Kate MKT, Waanders F, et al. High absolute risks and predictors of venous and arterial thromboembolic events in patients with nephrotic syndrome: results from a large retrospective cohort study. Circulation 117: 224-230, 2008.","DOI":"10.1161\/CIRCULATIONAHA.107.716951"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Johannesdottir SA, Puh\u00f3 EH, Dekkers OM, et al. Use of glucocorticoids and risk of venous thromboembolism: a nationwide population-based case-control study. JAMA Intern Med 173: 743-752, 2013.","DOI":"10.1001\/jamainternmed.2013.122"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Park JH, Han SW, Lee KY, et al. Impact of non-vitamin K antagonist oral anticoagulant withdrawal on stroke outcomes. Front Neurol 9: 1095, 2018.","DOI":"10.3389\/fneur.2018.01095"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/21\/60_7269-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T03:20:50Z","timestamp":1636168850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/60\/21\/60_7269-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,1]]},"references-count":23,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7269-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,1]]},"article-number":"7269-21"}}